Indenolol

Indenolol

SCHEMBL79021

CC(C)NCC(O)COc1cccc2c1C=CC2

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADRB2 P07550 10/20 0.56
▸ ADRB1 P08588 10/20 0.56
▸ ADRB3 P13945 4/20 0.56
▸ SIGMAR1 Q99720 4/20 0.56
▸ CYP1A2 P05177 4/20 0.56
▸ CYP2D6 P10635 4/20 0.56
▸ SLC6A4 P31645 4/20 0.56
▸ HTR2A P28223 4/20 0.56
▸ HTR2B P41595 3/20 0.56
▸ NR2E1 Q9Y466 3/20 0.56
▸ ALDH1A1 P00352 3/20 0.56
▸ HTR2C P28335 3/20 0.56
▸ HTR6 P50406 3/20 0.56
▸ HTR1A P08908 3/20 0.56
▸ LMNA P02545 3/20 0.56
▸ SCN1A P35498 2/20 0.56
▸ SLC10A1 Q14973 2/20 0.56
▸ SCN2A Q99250 2/20 0.56
▸ SCN3A Q9NY46 2/20 0.56
▸ SMN1; SMN2 Q16637 2/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Indenolol SCHEMBL79023 1.00 ADRB2 (0.56) ADRB2ADRB1ADRB3SIGMAR1CYP1A2
Indenolol SCHEMBL349114 0.99 ADRB2 (0.57) ADRB2ADRB1ADRB3SIGMAR1CYP1A2
Indenolol SCHEMBL349116 0.99 ADRB2 (0.57) ADRB2ADRB1ADRB3SIGMAR1CYP1A2
Indenolol SCHEMBL1650473 0.98 ADRB2 (0.54) ADRB2ADRB1ADRB3SIGMAR1CYP1A2
SCHEMBL11631654 0.93 ADRB2 (0.47) ADRB2ADRB1ADRB3SIGMAR1CYP1A2
SCHEMBL11656702 0.89 ADRB2 (0.44) ADRB2ADRB1ADRB3SIGMAR1CYP1A2
Idropranolol SCHEMBL1255318 0.88 ADRB1 (0.54) ADRB2ADRB1ADRB3SIGMAR1CYP1A2
Indenolol SCHEMBL11666579 0.86 ADRB2 (0.48) ADRB2ADRB1ADRB3SIGMAR1CYP1A2
SCHEMBL11754160 0.85 ALOX15 (0.41) ADRB2ADRB1ADRB3SIGMAR1CYP1A2
Hydrochloric Acid SCHEMBL11659927 0.84 ADRB2 (0.46) ADRB2ADRB1ADRB3SIGMAR1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 4643 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250213647-A1 CHEMOKINE RECEPTORS AND ALPHA1 ADRENERGIC RECEPTORS/VASOPRESSIN RECEPTORS 1A HETEROMERS AS DRUG TARGETS FOR DISEASE UNIVERSITY OF SOUTH FLORIDA 2025-07-03 — — US claimed
CN-119875866-A Recombinant saccharomycete and application thereof in fermentation production of beta-elemene 中国中医科学院中药研究所 2025-04-25 — — CN claimed
CN-119709731-A Programmable bicontinuous material based on DNA (deoxyribonucleic acid) aggregate as well as preparation method and application thereof 上海交通大学 2025-03-28 — — CN claimed
CN-118497083-B Pseudomonas and application thereof in prevention and treatment of branch blight of songaria tenuifolia 广东省林业科学研究院 2024-10-01 — — CN claimed
WO-2024185543-A1 ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM, PATTERN-FORMING METHOD, AND PRODUCTION METHOD FOR ELECTRONIC DEVICE 富士フイルム株式会社 2024-09-12 — — WO claimed
CN-118497083-A Pseudomonas and application thereof in prevention and treatment of branch blight of songaria tenuifolia 广东省林业科学研究院 2024-08-16 — — CN claimed
CN-118389370-A Nocardia YB-2 and application thereof in degrading vomitoxin 中国农业科学院北京畜牧兽医研究所 2024-07-26 — — CN claimed
CN-118017501-A Power grid aggregator regulation and control method 国网(山东)电动汽车服务有限公司 2024-05-10 — — CN claimed
CN-117987293-A Bacillus with antibacterial effect, microbial inoculum and application thereof 大连鑫玉龙海洋生物种业科技股份有限公司 2024-05-07 — — CN claimed
CN-116496929-B Bacillus suis and application thereof 西南科技大学 2023-11-28 — — CN claimed
EP-0156318-A2 C-terminal amide cyclic renin inhibitors containing peptide isosteres MERCK & CO. INC. (US) 1985-10-02 — — EP claimed
EP-0156322-A2 Renin inhibitors containing peptide isosteres MERCK & CO. INC. (US) 1985-10-02 — — EP claimed
EP-0153200-A2 Medicinal patch YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 1985-08-28 — — EP claimed
EP-0129189-A2 Renin inhibitors containing a C-terminal amide cycle and compositions and combinations containing the same MERCK & CO. INC. (US) 1984-12-27 — — EP claimed
EP-0105996-A1 Ophthalmic compositions for treating elevated intraocular pressure MERCK & CO. INC. (US) 1984-04-25 — — EP claimed
US-4303637-A Medication indicated for ocular hypertension ALZA CORPORATION (US) 1981-12-01 — — US claimed
EP-0037622-A2 Drug delivery insert for controlled ocular therapy ALZA CORPORATION (US) 1981-10-14 — — EP claimed
US-4281654-A Drug delivery system for controlled ocular therapy ALZA CORPORATION (US) 1981-08-04 — — US claimed
US-4127675-A BETA-RECEPTOR ANTAGONISTS YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1978-11-28 — — US claimed
US-4045482-A ADRENERGIC B-RECEPTOR BLOCKING AGENTS YAMANOUCHI PHARMACEUTICAL CO. LTD. (JA) 1977-08-30 — — US claimed
Send feedback